Antioxidants

Cleomiscosin C
Catalog No: CFN97400

Cleomiscosin C has antioxidant activity, it protects against the oxidative modification of apoB-100 induced by either Cu2+ or HOCl ( IC50s of 23.6 and 3.9 microM, respectively), suggests that it could be beneficial in preventing LDL oxidation in atherosclerotic lesions. Cleomiscosins A, B and C exhibit liver-protective properties.

Curculigoside
Catalog No: CFN97419

Curculigoside has potent antioxidant, anti-osteoporotic, immunomodulatory, and neuroprotective effects. Curculigoside can improve cognitive function in aged animals, possibly by decreasing the activity of AchE in the cerebra and inhibiting the expression of BACE1 in the hippocampus. Curculigoside exhibits potent inhibitory activity against matrix metalloproteinase-1 in cultured human skin fibroblasts, and increases the levels of ALP and Runx2 in osteoblasts under oxidative stress via anti-oxidative character.

Protosappanin B
Catalog No: CFN90135

Protosappanin B possesses antitumor, anti-inflammation and anti-oxidation properties, it protects PC12 cells against oxygen–glucose deprivation-induced neuronal death by maintaining mitochondrial homeostasis via induction of ubiquitin-dependent p53 protein degradation.

5-Hydroxy-1,7-diphenyl-6-hepten-3-one
Catalog No: CFN97433

5-Hydroxy-1,7-diphenyl-6-hepten-3-one has antioxidant activity.

6-Hydroxyrubiadin
Catalog No: CFN97444

6-Hydroxyrubiadin has antioxidant activity, EC(50) is 14.7ug/ml.